George Zogopoulos

7PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 26, 2026
Clinical and Molecular Correlates of Circulating Tumor Fraction in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

|Jul 02, 2025
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial.

Jennifer J Knox, Gun Ho Jang, Robert C Grant

|Apr 04, 2025
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer.

Abdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue

|Aug 09, 2023
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers.

Joan Miguel Romero, Emma Titmuss, Yifan Wang

|Jun 01, 2023
Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance.

Bryson W Katona, Kelsey Klute, Randall E Brand

|Oct 12, 2022
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma.

Sheron Perera, Gun Ho Jang, Yifan Wang

Pageof 2

Frequent Collaborators

4 joint publications

Yifan Wang

3 joint publications

Jennifer J Knox

3 joint publications

Faiyaz Notta

3 joint publications

Julie Wilson